Saturday 17 October 2026
Export MNTRQ’s income statement to Excel — free account
9 Meters Biopharma, Inc.
MNTRQ Healthcare Biotechnology
Follow MNTRQ
| Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | — | 4 |
P/E ratio |
— | — | — | — | — | — | 0.00 |
P/S ratio |
— | — | — | — | — | — | 2.38 |
P/FCF ratio |
— | — | — | — | — | — | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | — | (21.65) |
P/Operating CF |
— | — | — | — | — | — | (4.41) |
Beneish M-Score |
— | — | — | — | — | — | (0.08) |
P/B ratio |
— | — | — | — | — | — | 3.88 |
Price to Tangible BV |
— | — | — | — | — | — | 136.06 |
EV/Sales |
— | — | — | — | — | — | 2.10 |
EV/EBITDA |
— | — | — | — | — | — | 0.00 |
EV/Operating CF |
— | — | — | — | — | — | (1.01) |
EV/FCF |
— | — | — | — | — | — | (1.01) |
Quick Ratio |
0.41 | 5.56 | 5.53 | 0.31 | 0.57 | 0.03 | 0.58 |
Current Ratio |
1.08 | 5.91 | 5.68 | 0.35 | 0.63 | 0.06 | 1.01 |
Net Debt/EBITDA |
0.31 | 1.28 | 0.64 | 0.19 | 0.37 | 0.03 | 0.35 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.73 |
Operating CF/Net income |
0.85 | 0.80 | 0.32 | 0.66 | 0.63 | 0.44 | 1.36 |
Capex/Depreciation |
0.00 | (0.24) | 0.00 | (0.01) | (0.01) | (0.85) | 0.00 |
Interest Coverage |
(15.75) | (778.85) | (15.05) | (14.00) | (2.96) | (25.60) | (7.20) |
| (198.92%) | (99.75%) | (545.95%) | 407.57% | 305.20% | 239.63% | 387.59% | |
| (105.05%) | (82.34%) | (276.67%) | (460.37%) | (666.30%) | (319.61%) | (111.13%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (358.88%) |
Return on Tangible Assets |
(1,876.45%) | (88.53%) | (191.64%) | 279.94% | 659.33% | 95.28% | (10,900.00%) |
Average Days of Receivables |
— | — | — | — | — | 0.00 | 76.86 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.64% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 157.66% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.37 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | — | — | — | — | — | 0.01 |
Graham Number |
— | — | — | — | — | — | 0.00 |
Earnings Yield |
— | — | — | — | — | — | (50.86%) |
Free Cash Flow Yield |
— | — | — | — | — | — | (87.24%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 147.28 |
Operating CF per Share |
(2.87) | (2.43) | (3.67) | (10.78) | (12.25) | (8.57) | (305.33) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | (0.01) | (0.07) | 0.00 |
Free Cash Flow per Share |
(2.87) | (2.43) | (3.68) | (10.79) | (12.26) | (8.64) | (305.33) |
Cash per Share |
0.98 | 3.87 | 7.17 | 2.76 | 4.63 | 0.60 | 52.64 |
Shareholders Equity per Share |
0.19 | 3.42 | 6.09 | (5.77) | (2.96) | (20.48) | 90.14 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.19 | 3.42 | 6.09 | (5.77) | (2.96) | (20.48) | 90.14 |
Free Cash Flow |
(37.25) | (29.49) | (19.41) | (17.98) | (15.18) | (5.14) | (8.43) |
Working Capital |
2.32 | 41.53 | 32.08 | (9.69) | (3.70) | (12.22) | 0.06 |
Capital Expenditures |
0.00 | (0.01) | 0.00 | (0.01) | (0.01) | (0.04) | — |
Net Current Asset Value |
2.27 | 41.42 | 31.91 | (9.69) | (3.70) | (12.22) | 0.06 |
EV/EBIT |
— | — | — | — | — | — | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
— | — | — | — | — | — | 0.00 |
| Other line items | |||||||
Depreciation/Fixed assets |
176.93 | 3.21 | 137.34 | 42.87 | 72.17 | 1.11 | 0.00 |
Cash ROIC |
(247.53%) | (33.29%) | (27.73%) | 358.09% | (733.56%) | 43.45% | (213.83%) |
Accounts Receivable Turnover |
— | — | — | — | — | 0.00 | 5.42 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.17 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.83 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 29.38 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 121.16 |
Average Receivables |
— | — | — | — | — | 0.47 | 0.75 |
Average Payables |
3.74 | 1.96 | 2.69 | 3.75 | 3.14 | 1.46 | 0.64 |
Average Inventory |
— | — | — | — | — | — | 0.87 |
Average Assets |
41.66 | 44.67 | 22.23 | 5.88 | 3.63 | 3.63 | 5.59 |
Average Common Equity |
22.00 | 36.87 | 11.26 | (6.64) | (7.92) | (4.84) | (1.60) |
Columns are period end dates